Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

http://www.wikidata.org/entity/Q45985006

about

Cholinergic imaging in dementia spectrum disorders Functional neuroimaging in Parkinson's disease Neuroimaging of Parkinson's disease: Expanding views.Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.Enhanced functional connectivity between putamen and supplementary motor area in Parkinson's disease patients The cholinergic system and Parkinson disease.Cholinergic dysfunction in Parkinson's disease.Can nicotine be used medicinally in Parkinson's disease?Dyskinesias in Parkinson's disease: views from positron emission tomography studies.Molecular imaging of levodopa-induced dyskinesias.Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies.Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.

P2860

Q26764933-41FD22A6-3F0F-4586-96B2-BECB773D9CF3 Q27013767-67A86B1A-DB40-4537-ACB1-9386713272F2 Q28387732-21EA09D8-2ACB-4C92-B5A0-060D829CDF4E Q33954007-FF6A633C-2BF0-4AA4-B4C9-DCFFFDDCB36E Q34652006-3501F30C-913C-4731-BADC-949B0877C256 Q37671065-750D6404-8D11-479E-ACFF-12C75B45DB4F Q37709932-181B7CD3-FEF2-455A-8112-011D06CAEA6E Q37960523-7007AAA1-03D0-4132-9E13-AFBD370E133E Q38182651-A516A9D8-B760-4FF3-B0EE-B83AE8F3F889 Q38355582-1B6179C9-B28D-4B08-AD2A-3EFA1EFF7CEE Q38840893-871E50A6-D738-4A91-BCDF-4F9A238B62F4 Q42369736-82ABD495-CA9A-4965-B364-E09D53CA3BFB Q42789671-67329552-CE9C-4E4A-8551-15470EAA2147 Q48720779-9CB63DA2-5F46-4CFA-8E62-6328273F819B Q48870423-42EAC124-C2D5-4F90-99C4-EC2BF904070D

P2860

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

http://www.wikidata.org/entity/Q45985006

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@en

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@nl

type

label

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@en

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@nl

prefLabel

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@en

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@nl

P1433

Q45985006-7F7E0721-780F-4794-BEBA-F7FECDCACFDC

P1476

Q45985006-B77EB2C1-49A5-4DDF-9308-3B6211A0FF6C

P2093

Q45985006-124A8619-497D-4C4F-BBCB-6F1421BF7C67

Q45985006-1CEB7188-09DA-4EB1-8CB2-19CC4D4B7162

Q45985006-2FD9717E-24E9-45CF-BD76-3D405F8935BC

Q45985006-37C6E6CD-A4E2-4BB2-B469-02D39FCD2337

Q45985006-49037200-EC3B-4D80-A85E-991602600E7F

Q45985006-5981321F-26E0-404D-86F0-FF9D8ECBDE71

Q45985006-648F11E2-9BDC-42EF-BFFC-7ED6D71DFB46

Q45985006-6AC90FE9-1A5B-4192-8A92-6D58980FDD5B

Q45985006-C0EEF58B-1800-465F-B7B1-126710106CA1

Q45985006-F97A7BC0-E6E7-4C09-A85C-0333175233C3

P2860

Q45985006-04661748-DBC5-4BAD-A27B-F19D066FBAD9

Q45985006-0C4B21E9-C6AA-4AD5-A41C-36B444FEB548

Q45985006-0EDE42A0-F26D-4373-BB5C-3CD57B7D38F0

Q45985006-1F437FD7-36A4-4667-AE60-F8E045A8F65E

Q45985006-1FBCD6CA-1258-4069-B2C4-7ED7A142AA39

Q45985006-29C56F17-2EB1-4AE2-A6BC-F965034FA83A

Q45985006-31D499CF-AA52-4D8C-A480-BBF04A79ED10

Q45985006-33ED69FB-0208-40D7-A2EE-F17974595329

Q45985006-43BC0837-D9B9-4266-B1B2-F25E213DFF5F

Q45985006-51D6BF09-C7AE-493E-AFA9-2CAF4B277F58

P304

Q45985006-7EB83A4C-1899-4515-9849-EB27A2929070

P31

Q45985006-A3840EF9-C2F7-4A3B-8297-60696F2B01F7

P356

Q45985006-601AC973-A2F4-4479-AFF0-6BE09843E216

P433

Q45985006-8434E3E0-4DE7-448A-BADE-680922DB1732

P478

Q45985006-91EFDE75-E42E-4C17-875A-9799F8CB6013

P50

Q45985006-303EBF84-D2EF-4174-BF40-24837D4ABAC9

Q45985006-A3A0F119-475A-457E-89A3-18E49A680D24

P577

Q45985006-F80DE985-DD75-49F2-801A-B6F78947D4FB

P5875

Q45985006-5B5FBEE8-489F-44FD-A4EE-B81ABFB0179E

P698

Q45985006-A9BFB06E-A48B-4AF2-A702-F86C4FACFD28

P921

Q45985006-BC2FD45E-6037-49CD-8C68-E5F6D4B12583

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.

@en

P2093

Aurélie Kas

http://www.w3.org/2001/XMLSchema#string

Christine Coulon

http://www.w3.org/2001/XMLSchema#string

Frédéric Dollé

http://www.w3.org/2001/XMLSchema#string

Gabriel Villafane

http://www.w3.org/2001/XMLSchema#string

Héric Valette

http://www.w3.org/2001/XMLSchema#string

Jean Dominique Gallezot

http://www.w3.org/2001/XMLSchema#string

Maria-Joao Ribeiro

http://www.w3.org/2001/XMLSchema#string

Marie Claude Grégoire

http://www.w3.org/2001/XMLSchema#string

Michel Bottlaender

http://www.w3.org/2001/XMLSchema#string

Philippe Hantraye

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease protects against smoking?

“Mini-mental state”

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

Smoking, nicotine and Parkinson's disease

Neuronal nicotinic receptors: from structure to pathology

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature.

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2* nAChRs in mouse, monkey, and Parkinson's disease striatum.

P304

1601-1608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2009.74

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Marie Vidailhet

P577

2009-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26262464

http://www.w3.org/2001/XMLSchema#string

P698

19491921

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease